相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma
Julia S. Gerke et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
Hua Zhang et al.
CANCER CELL (2020)
Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors
William Hankey et al.
CANCER RESEARCH (2020)
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects againstMYCN-amplified neuroblastoma
Andrew E. Tee et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
Emily J. Faivre et al.
NATURE (2020)
Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy
Jonathan Chou et al.
CANCER DISCOVERY (2020)
Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer
Masayuki Nagasawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
CDK7 inhibitors as anticancer drugs
Georgina P. Sava et al.
CANCER AND METASTASIS REVIEWS (2020)
Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells
Qi Ma et al.
CELL REPORTS (2020)
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation
Simon J. Baumgart et al.
MOLECULAR ONCOLOGY (2020)
The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells
Marie C. Hupe et al.
WORLD JOURNAL OF UROLOGY (2019)
The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program
Viktoria Kalna et al.
CIRCULATION RESEARCH (2019)
Super-enhancers in cancer
Palaniraja Thandapani
PHARMACOLOGY & THERAPEUTICS (2019)
Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7
Shanhu Hu et al.
CANCER RESEARCH (2019)
Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity
Yali Ding et al.
LEUKEMIA (2019)
Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
Yi He et al.
FRONTIERS IN PHARMACOLOGY (2019)
The SNP of rs6854845 suppresses transcription via the DNA looping structure alteration of super-enhancer in colon cells
Zhuangzhi Cong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues
Hongjie Chen et al.
HUMAN GENETICS (2019)
Dysregulated Transcriptional Control in Prostate Cancer
Simon J. Baumgart et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Regulatory Landscaping: How Enhancer-Promoter Communication Is Sculpted in 3D
Michael I. Robson et al.
MOLECULAR CELL (2019)
Chemical genomics reveals histone deacetylases are required for core regulatory transcription
Berkley E. Gryder et al.
NATURE COMMUNICATIONS (2019)
Liquid–Liquid Phase Separation in Disease
Simon Alberti et al.
Annual Review of Genetics (2019)
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation
Reyaz Ur Rasool et al.
CANCER DISCOVERY (2019)
Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1
Joshua W. Russo et al.
CANCER DISCOVERY (2019)
CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines
Veronica Garcia-Carpizo et al.
MOLECULAR CANCER RESEARCH (2019)
SEdb: a comprehensive human super-enhancer database
Yong Jiang et al.
NUCLEIC ACIDS RESEARCH (2019)
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
Harri M. Itkonen et al.
THERANOSTICS (2019)
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)
Jonathan Welti et al.
CLINICAL CANCER RESEARCH (2018)
Enhancer transcription: what, where, when, and why?
Nathaniel D. Tippens et al.
GENES & DEVELOPMENT (2018)
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle
John A. Hanover et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2018)
Bromodomain-containing proteins in prostate cancer
Alfonso Urbanucci et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
Urszula L. McClurg et al.
ONCOGENE (2018)
Coactivator condensation at super-enhancers links phase separation and gene control
Benjamin R. Sabari et al.
SCIENCE (2018)
Transcriptional Regulation in Prostate Cancer
David P. Labbe et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer
Ling Cai et al.
MOLECULAR CELL (2018)
Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II
Huasong Lu et al.
NATURE (2018)
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
Adam D. Durbin et al.
NATURE GENETICS (2018)
BRD4 and Cancer: going beyond transcriptional regulation
Benedetta Donati et al.
MOLECULAR CANCER (2018)
O-GlcNAc as an Integrator of Signaling Pathways
Qunxiang Ong et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities
Jing-Yan Tian et al.
CARCINOGENESIS (2018)
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
K. T. Siu et al.
LEUKEMIA (2017)
Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
Emily J. Faivre et al.
MOLECULAR CANCER RESEARCH (2017)
Exploiting Epigenetic Alterations in Prostate Cancer
Simon J. Baumgart et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Haematopoietic stem and progenitor cells from human pluripotent stem cells
Ryohichi Sugimura et al.
NATURE (2017)
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
Ken J. Kron et al.
NATURE GENETICS (2017)
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
Xiangpeng Dai et al.
NATURE MEDICINE (2017)
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation
Pingzhao Zhang et al.
NATURE MEDICINE (2017)
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Hana Janouskova et al.
NATURE MEDICINE (2017)
Towards quantitative analysis of gene regulation by enhancers
Ekaterina V. Nizovtseva et al.
EPIGENOMICS (2017)
Mechanisms of Therapeutic Resistance in Prostate Cancer
Mary Nakazawa et al.
CURRENT ONCOLOGY REPORTS (2017)
The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma
Jiyuan Zhang et al.
CANCER DISCOVERY (2017)
Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells
Yangyang Han et al.
THERANOSTICS (2017)
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
Alfonso Urbanucci et al.
CELL REPORTS (2017)
Human TFIIH Kinase CDK7 Regulates Transcription-Associated Chromatin Modifications
Christopher C. Ebmeier et al.
CELL REPORTS (2017)
Androgen Signaling in Prostate Cancer
Charles Dai et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
Neel Shah et al.
ELIFE (2017)
SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitors
Xiangpeng Dai et al.
CELL CYCLE (2017)
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
Mai H. Bui et al.
CANCER RESEARCH (2017)
The ETS family of oncogenic transcription factors in solid tumours
Gina M. Sizemore et al.
NATURE REVIEWS CANCER (2017)
Combinatorial function of transcription factors and cofactors
Franziska Reiter et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
A Phase Separation Model for Transcriptional Control
Denes Hnisz et al.
CELL (2017)
SEA: a super-enhancer archive
Yanjun Wei et al.
NUCLEIC ACIDS RESEARCH (2016)
The oncogene ERG: a key factor in prostate cancer
P. Adamo et al.
ONCOGENE (2016)
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
Isabel Coutinho et al.
ENDOCRINE-RELATED CANCER (2016)
MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator
Chen-Yi Jiang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
Irfan A. Asangani et al.
MOLECULAR CANCER RESEARCH (2016)
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
Jinghui Zhang et al.
NATURE GENETICS (2016)
BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
Ballachanda N. Devaiah et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Regulatory Enhancer-Core-Promoter Communication via Transcription Factors and Cofactors
Muhammad A. Zabidi et al.
TRENDS IN GENETICS (2016)
BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
Ballachanda N. Devaiah et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism
Radhika Kandaswamy et al.
CELL REPORTS (2016)
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Yubao Wang et al.
CELL (2015)
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
Michela Boi et al.
CLINICAL CANCER RESEARCH (2015)
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Derek A. Oldridge et al.
NATURE (2015)
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M. Pomerantz et al.
NATURE GENETICS (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
TMPRSS2: ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation
Z. Mounir et al.
ONCOGENE (2015)
Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
Yeqing Angela Yang et al.
GENES & DISEASES (2015)
Liquid-Liquid Phase Separation in Biology
Anthony A. Hyman et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
BET bromodomain inhibitors-A novel epigenetic approach in castration-resistant prostate cancer
Sarah E. Lochrin et al.
CANCER BIOLOGY & THERAPY (2014)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Edmond Chipumuro et al.
CELL (2014)
The 3D Genome in Transcriptional Regulation and Pluripotency
David U. Gorkin et al.
CELL STEM CELL (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Enhancer Function: Mechanistic and Genome-Wide Insights Come Together
Jennifer L. Plank et al.
MOLECULAR CELL (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Can genome engineering be used to target cancer-associated enhancers?
Matthew R. Grimmer et al.
EPIGENOMICS (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
ERG protein expression as a biomarker of prostate cancer
Sara Moscovita Falzarano et al.
BIOMARKERS IN MEDICINE (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Warren A. Whyte et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer
Christopher Weier et al.
JOURNAL OF PATHOLOGY (2013)
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
Ayesha A. Shafi et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process
Pierre Chymkowitch et al.
EMBO JOURNAL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
ETS gene fusions in prostate cancer
Jeremy P. Clark et al.
NATURE REVIEWS UROLOGY (2009)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Cyclin H binding to the RARα activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7
G Bour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mammalian cyclin-dependent kinases
M Malumbres et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation
N Gao et al.
DEVELOPMENT (2005)
XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα
A Keriel et al.
CELL (2002)
分享论文
